| Summary of Goodwill, net of Effect of Foreign Currency Exchange Adjustments and Goodwill Impairment Charge |
The following table summarizes goodwill, net of the effect of foreign currency exchange adjustments and the goodwill impairment charge, for the twelve months ended June 30, 2026 and 2025, respectively:
|
|
|
|
|
|
|
|
|
Acquisition |
|
June 30, 2026 |
|
|
June 30, 2025 |
|
Iliad Chemicals Pty Ltd acquisition |
|
$ |
4,700,360 |
|
|
$ |
4,478,747 |
|
Eclipse Therapeutics, Inc. acquisition |
|
|
4,159,862 |
|
|
|
4,159,862 |
|
|
|
$ |
8,860,222 |
|
|
$ |
8,638,609 |
|
Goodwill impairment |
|
|
(5,362,000 |
) |
|
|
- |
|
|
|
$ |
3,498,222 |
|
|
$ |
8,638,609 |
|
|
|
|
|
|
|
|
Carrying amount at June 30, 2025 |
|
|
|
|
$ |
8,638,609 |
|
Foreign currency exchange differences |
|
|
|
|
|
221,613 |
|
Goodwill impairment |
|
|
|
|
|
(5,362,000 |
) |
Carrying amount at June 30, 2026 |
|
|
|
|
$ |
3,498,222 |
|
|
|
|
|
|
|
|
Carrying amount at June 30, 2024 |
|
|
|
|
$ |
8,690,018 |
|
Foreign currency exchange differences |
|
|
|
|
|
(51,409 |
) |
Carrying amount at June 30, 2025 |
|
|
|
|
$ |
8,638,609 |
|
|